On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

DENVER, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire / -- How Big Is The Human Serum Albumin Market In 2025?

With the aim of streamlining the regulatory process for biopharmaceutical manufacturers engaged in vaccine, recombinant DNA, ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

Danaher faces revenue pressure and rising leverage despite strong market exposure, making its high valuation harder to ...

Elena Erroba is the group CCO at 3PBIOVIAN. She specializes in the development and manufacturing of recombinant proteins and advanced therapies, including viral vectors—such as adenoviruses and ...

The Global DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.2% from 2025 ...

The CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are ...

Recombinant DNA technology in medicine, agriculture and forensic sciences. Computational Biology: Bioinformatics; Sequence and structure databases; DNA, RNA and protein sequence analysis; Secondary ...

The remains of someone who was found 16 years ago have finally been identified, thanks to advanced DNA technology. On April 30, 2009, human remains were discovered in a field near Meadows Elementary ...